Does LISOCABTAGENE MARALEUCEL Cause Hyperglycaemia? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hyperglycaemia have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 0.7% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
5
Reports of Hyperglycaemia with LISOCABTAGENE MARALEUCEL
0.7%
of all LISOCABTAGENE MARALEUCEL reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hyperglycaemia From LISOCABTAGENE MARALEUCEL?
Of the 5 reports, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LISOCABTAGENE MARALEUCEL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Hyperglycaemia Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE